These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 20171430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
    Hung YP, Lee NY, Chang CM, Lee HC, Wu CJ, Chen PL, Lee CC, Chung CH, Ko WC.
    Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
    [Abstract] [Full Text] [Related]

  • 4. High risk of cross-reactivity between vancomycin and sequential teicoplanin therapy.
    Hsiao SH, Chou CH, Lin WL, Lee EJ, Liao LH, Chang HJ, Yeh PY, Lin CY, Wu TJ.
    J Clin Pharm Ther; 2012 Jun; 37(3):296-300. PubMed ID: 22017186
    [Abstract] [Full Text] [Related]

  • 5. Clinical usefulness of patch and challenge tests in the diagnosis of cell-mediated allergy to betalactams.
    Patriarca G, D'Ambrosio C, Schiavino D, Larocca LM, Nucera E, Milani A.
    Ann Allergy Asthma Immunol; 1999 Sep; 83(3):257-66. PubMed ID: 10507273
    [Abstract] [Full Text] [Related]

  • 6. Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin.
    Hsiao SH, Chang CM, Tsai JC, Lin CY, Liao LH, Lin WL, Wu TJ.
    Ann Pharmacother; 2007 May; 41(5):891-4. PubMed ID: 17426073
    [Abstract] [Full Text] [Related]

  • 7. [Cutaneous adverse drug reactions: enhanced imputation score by skin testing].
    Choquet-Kastylevsky G, Vial T, Santolaria N, Nageotte A, Faure M, Claudy A, Descotes J.
    Ann Dermatol Venereol; 2001 Apr; 128(4):507-11. PubMed ID: 11395648
    [Abstract] [Full Text] [Related]

  • 8. The usefulness of skin tests to prove drug hypersensitivity.
    Lammintausta K, Kortekangas-Savolainen O.
    Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154
    [Abstract] [Full Text] [Related]

  • 9. Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins.
    Barbaud A, Trechot P, Weber-Muller F, Ulrich G, Commun N, Schmutz JL.
    Contact Dermatitis; 2004 Jan; 50(1):22-6. PubMed ID: 15059099
    [Abstract] [Full Text] [Related]

  • 10. DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6.
    Tamagawa-Mineoka R, Katoh N, Nara T, Nishimura Y, Yamamoto S, Kishimoto S.
    Int J Dermatol; 2007 Jun; 46(6):654-5. PubMed ID: 17550572
    [No Abstract] [Full Text] [Related]

  • 11. [Cutaneous drug reactions induced by glycopeptides].
    Prey S, Sparsa A, Boumediene A, Bonnetblanc JM, Weinbreck P, Denes E.
    Med Mal Infect; 2007 May; 37(5):270-4. PubMed ID: 17434698
    [Abstract] [Full Text] [Related]

  • 12. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006].
    Kacalak-Rzepka A, Klimowicz A, Bielecka-Grzela S, Załuga E, Maleszka R, Fabiańczyk H.
    Ann Acad Med Stetin; 2008 May; 54(2):52-8. PubMed ID: 19374232
    [Abstract] [Full Text] [Related]

  • 13. [Skin tests in the study of drug eruptions with suspected immuno-allergic mechanism].
    Barbaud A, Béné MC, Faure G, Schmutz JL.
    Bull Acad Natl Med; 2000 May; 184(4):775-91. PubMed ID: 10989563
    [Abstract] [Full Text] [Related]

  • 14. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.
    Lammintausta K, Kortekangas-Savolainen O.
    Acta Derm Venereol; 2005 May; 85(6):491-6. PubMed ID: 16396795
    [Abstract] [Full Text] [Related]

  • 15. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L, Encinas MP, Morín LS, Vilches P, Gutiérrez N, García-Sanz R, Caballero D, Hurlé AD.
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [Abstract] [Full Text] [Related]

  • 16. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
    Chattopadhyay C, Chakrabarti N.
    Niger J Clin Pract; 2012 Mar; 15(2):194-8. PubMed ID: 22718172
    [Abstract] [Full Text] [Related]

  • 17. Skin testing in delayed reactions to drugs.
    Barbaud A.
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):517-35. PubMed ID: 19563995
    [Abstract] [Full Text] [Related]

  • 18. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A, Palau E, Puerro M, Vargas E, Picazo JJ.
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [Abstract] [Full Text] [Related]

  • 19. Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions.
    Waton J, Tréchot P, Loss-Ayav C, Schmutz JL, Barbaud A.
    Br J Dermatol; 2009 Apr; 160(4):786-94. PubMed ID: 19120340
    [Abstract] [Full Text] [Related]

  • 20. Value of patch tests in clindamycin-related drug eruptions.
    Pereira N, Canelas MM, Santiago F, Brites MM, Gonçalo M.
    Contact Dermatitis; 2011 Oct; 65(4):202-7. PubMed ID: 21689110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.